Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
Clinical trial NCT07610434 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07610434
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2028-01-31
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.